Electra Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, CA, January 6, 2025 – Electra Therapeutics, a clinical stage biotechnology company developing antibody therapies against novel targets for immunological diseases and cancer, today announced that it will present at the 43rd annual J.P. Morgan Healthcare Conference….